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Objective: The objective of this study was to investigate the protective effects
of nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester hydro-
chloride, on reperfusion injury of the brain under hypothermic circulatory
arrest. Methods: After cardiopulmonary bypass was established using 12
piglets each weighing about 30 kg, the animals were cooled to a brain
temperature of 20° C and circulatory arrest was performed for 90 minutes
followed by reperfusion for 120 minutes. The level of nitric oxide within the
brain was measured with a needle electrode inserted into the brain. In the
treatment group, NG-nitro-L-arginine methyl ester hydrochloride was ad-
ministered with an intravenous injection of 1.5 mg/kg at the onset of the
reperfusion followed by a 60-minute continuous venous infusion of 1.5
mg/kg/hr. Results: In the control group, nitric oxide levels within the brain
increased not during ischemia but during reperfusion, and the level after
120 minutes of reperfusion increased significantly compared with that of
before circulatory arrest. But in the treatment group, NG-nitro-L-arginine
methyl ester hydrochloride administered at the onset of reperfusion
inhibited nitric oxide production during reperfusion. A significant differ-
ence was observed between the groups regarding the nitric oxide level after
120 minutes of reperfusion. Regarding cerebral blood flow, excess lactate,
and cerebral tissue water content, no significant difference was observed
between the groups. However, recovery of somatosensory evoked potential
after 120 minutes of reperfusion was detected in all six animals in the
treatment group, but none in the control group (p 5 0.001). Conclusion:
These data suggest that NG-nitro-L-arginine methyl ester hydrochloride
protects the brain against reperfusion injury under hypothermic circula-
tory arrest. (J Thorac Cardiovasc Surg 1998;115:925-30)
During operation of the aortic arch, a risk ofcerebral damage, resulting from restriction of
cerebral blood supply, is present. Therefore various
techniques for cerebral protection during ischemia,
for example hypothermic circulatory arrest, selective
cerebral perfusion, and retrograde cerebral perfu-
sion, are used. Hypothermic circulatory arrest is
easy to perform but it is not suitable for longer
operations. The other techniques are more compli-
cated and difficult to perform.
During normothermic cerebral ischemia, nitric
oxide (NO) within the brain is overproduced, and
the overproduced NO is thought to be neurotoxic.1
However, the role of NO during reperfusion after
hypothermic circulatory arrest has not been investi-
gated.
The aim of this study was to measure the levels of
NO within the brain during ischemia with hypother-
mic circulatory arrest and reperfusion using cardio-
pulmonary bypass (CPB) and furthermore to inves-
tigate the effect of an NO synthase inhibitor (NOSI)
on the cerebral reperfusion injury.
Materials and methods
Experimental preparations. Twelve farm piglets of ei-
ther sex, weighing 31 to 35 kg, were premedicated with an
intramuscular injection of 20 mg/kg ketamine hydrochlo-
From the Department of Surgery II, National Defense Medical
College, Saitama, Japan.
Received for publication March 20, 1997; revisions requested
Sept. 15, 1997; revisions received Oct. 8, 1997; accepted for
publication Oct. 9, 1997.
Address for reprints: Daisuke Segawa, MD, Department of
Surgery II, National Defense Medical College, 3-2 Namiki,
Tokorozawa, Saitama 359, Japan.
Copyright © 1998 by Mosby, Inc.
0022-5223/98 $5.00 1 0 12/1/86883
9 2 5
ride and 1.0 mg/kg body weight atropine sulfate. Anesthe-
sia was induced with an intravenous injection of 20 mg/kg
sodium pentobarbital and maintained with a continuous
intravenous infusion of sodium pentobarbital, 10 mg/kg/
hr, and an intermittent intravenous injection of 1 mg/kg
body weight/hr pancuronium bromide. The tracheas of the
piglets were intubated and the piglets’ lungs were mechan-
ically ventilated with a respirator with room air. Respira-
tory rate and tidal volume were adjusted to keep arterial
pH between 7.35 and 7.45 and carbon dioxide tension
(Pco2) between 35 and 45 mm Hg. A 7F catheter was
inserted into the left femoral vein for administration of
fluids, and another 7F catheter was inserted into the
external jugular vein for withdrawal of venous blood
specimens from the brain circulation. A 6F catheter
inserted into the left femoral artery was connected to a
transducer (RM-6000, Nihon Koden, Saitama, Japan) for
measurement of blood pressure and was used for with-
drawal of arterial blood specimens.
Craniotomy was performed and a needle electrode, 0.2
mm in diameter (NOE-55, Intermedical Inc., Tokyo,
Japan), for measurement of NO within the brain was
inserted into the cortex of the right temporal lobe through
the dura mater. The electrode was connected with a NO
monitor (model NO-501, Intermedical Inc., Tokyo, Ja-
pan). This monitor expressed NO levels continuously as
pico-amperes.2 In the same way, a needle electrode
(HGE-10N, Intermedical Inc., Tokyo, Japan) for mea-
surement of regional cerebral blood flow was inserted
near the NO needle electrode and connected with a
hydrogen clearance–type monitor (model-HG-200, Inter-
medical Inc., Tokyo, Japan). To obtain a somatosensory
evoked potential (SEP) by stimulating the left radial
nerve, working and counter electrodes of an electroen-
cephalograph were put on the surfaces of the right
temporary lobe and the frontal lobe, respectively, and
connected to a recorder (MEB-5200, Nihon Koden,
Saitama, Japan). To monitor the temperature of the brain,
a microprobe connected to a thermometer (model TH-6,
Bailey, N.J.) was put between the cranial bone and dura
mater in the occipital region.
Through a right pararectus incision the right external
iliac artery was extraperitoneally exposed. Right thoracot-
omy was performed in the fourth intercostal space, and
the pericardium was opened. After administration of
heparin, 300 IU/kg, a 16F perfusion cannula was inserted
into the iliac artery and 30F and 32F drainage cannulas
were inserted through the right atrium into the superior
and inferior caval veins, respectively, and CPB was estab-
lished.
The experimental protocol and animal care was ap-
proved by the local ethics committee for animal research,
which conforms to the “Guide for the Care and Use of
Laboratory Animals,” published by U.S. National Insti-
tutes of Health (NIH publication No. 85-23, revised 1985).
Experimental protocol. The CPB circuit was primed
with Ringer’s lactate to achieve a hematocrit value of 20%
to 25% and a flow rate of CPB was maintained at 50
ml/kg/min. The arterial Pco2 was kept at 35 to 45 mm Hg
and oxygen tension (Po2) at 450 to 500 mm Hg. To keep
arterial pH between 7.35 and 7.45 during CPB, the proper
dose of sodium bicarbonate was occasionally infused
according to blood base excess. Animals were cooled to a
brain temperature of 20° C and circulatory arrest was
performed for 90 minutes followed by reperfusion for 120
minutes. NO levels within the brain were measured
throughout this period from pre-CPB to the end of
reperfusion. In the treatment group, an NOSI, NG-nitro-
L-arginine methyl ester hydrochloride (L-NAME), was
administered with an intravenous injection of 1.5 mg/kg at
the onset of reperfusion, followed by a 60-minute contin-
uous venous infusion of 1.5 mg/kg/hr. In the control group
the same volume of saline solution was administered.
Body and brain temperatures, NO levels, and SEP were
measured before CPB, at the beginning of CPB, before
circulatory arrest, after 90 minutes of circulatory arrest,
and after 60 and 120 minutes of reperfusion. Blood
pressure and regional cerebral blood flow were measured
before CPB, at the beginning of CPB, before circulatory
arrest, at the beginning of reperfusion, and after 60 and
120 minutes of reperfusion.
Postmortem study. At the end of the study the animals
were killed by cessation of CPB and the brains were
excised immediately. Cerebral tissue water content was
calculated as the following formula with wet and dry
weights of the brain. The dry weight was obtained after
desiccation at 80° C for 48 hours. Cerebral tissue water
content (%) 5 (Wet weight – Dry weight)/Wet weight 3
100.
Plasma study. Five milliliters of arterial specimens
from the left femoral artery and 2 ml of venous specimens
from the right external jugular vein were drawn before
CPB, just before circulatory arrest, just after circulatory
arrest, and after 120 minutes of reperfusion. Two millili-
ters of the arterial specimens and venous specimens were
mixed with trichloroacetic-hydrochloric acid and centri-
fuged immediately for analysis of lactate and pyruvate.
The remaining arterial specimens were collected in hep-
arinized tubes and centrifuged immediately for analysis of
aspartate aminotransferase (AST) and lactic dehydroge-
nase (LD). All plasma samples were removed and kept at
–80° C until analysis.
Lactate and pyruvate concentration were measured by
lactate or pyruvate oxidase method, AST by ultraviolet
method, and LD by Wroblewski-LaDue method. Excess
lactate was calculated from lactate and pyruvate concen-
tration in the artery and vein with Huckabeels method.3
To eliminate the effects of dilution for CPB, these
obtained data were corrected as follows with the level of
hematocrit. Corrected level 5 Hematocrit at pre-CPB/
hematocrit at measurement 3 measured level.
Randomization procedure. Randomization was per-
formed with a randomization code. The study was planned
to include at least six successfully studied animals in each
group. The investigators responsible for the surgical pro-
cedure were not informed of treatment allocation. All
measurements, including NO levels, were also performed
blindly.
Data analysis. Statistical analysis was performed with
nonparametric tests because the data obtained in this
study were not expected to be normal distributions. Mann-
Whitney rank-sum test was used for comparison between
the two groups. Comparisons within the group were
performed by Friedman test and, if significant, further
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analysis was made with the Student-Newman-Keuls test
for all possible pairwise comparisons. All data are pre-
sented as mean 6 standard deviation.
Results
Changes of body and brain temperatures. The
average body weight of piglets in the control and the
treatment groups was 32.2 6 1.5 and 33.3 6 1.9 kg,
respectively. Cooling periods to a brain temperature
of 20° C were 37.0 6 3.9 and 37.2 6 4.2 minutes,
respectively. No significant difference was observed
between the groups regarding body weight and
cooling period. Body and brain temperatures are
shown in Table I. The two groups were similar
throughout the experiment regarding body and
brain temperatures and no significant difference was
observed between the groups.
Blood pressure and regional cerebral blood flow.
Blood pressure and regional cerebral blood flow are
shown in Table I. In the control group blood pres-
sure decreased from 126 6 15 mm Hg to 64 6 12
mm Hg on starting CPB and after that it hardly
changed throughout the course, even during reper-
fusion. In the treatment group blood pressure de-
creased from 133 6 19 mm Hg to 76 6 12 mm Hg
on starting CPB and until reperfusion it did not
change remarkably. However, blood pressure in-
creased gradually after reperfusion started and
reached 85 6 31 mm Hg after 60 minutes of
reperfusion and 101 6 39 after 120 minutes. How-
ever, this increase of blood pressure in the treatment
group remained within the physiologic range. On
the other hand, no significant difference was ob-
served between the groups regarding cerebral blood
flow at any phase, even after 120 minutes of reper-
fusion.
AST and LD of plasma, and excess lactate. AST
and LD of plasma and calculated excess lactate are
shown in Table I. Both AST and LD gradually
increased in the course of the experiment. The two
groups were comparable and no significant differ-
ence was observed between the groups. Excess
lactate levels decreased during the course of the
experiment in both the groups. No significant differ-
ence was observed between the groups in the levels
of cerebral excess lactate at any phase.
Changes of NO levels within the brain. NO levels
within the brain before CPB in the control and the
treatment groups were 3744 6 2665 and 3157 6
1806 pA, respectively. The levels at the beginning of
CPB were 3358 6 2412 and 3005 6 1848 pA.
Because no significant difference was observed be-
tween the groups regarding these levels, the levels at
pre-CPB, precirculatory arrest, after 90 minutes of
circulatory arrest, and after 60 and 120 minutes of
reperfusion were described as a percentage of the
level at the beginning of CPB (Fig. 1). In both
groups NO levels decreased in proportion to de-
crease of brain temperature during the cooling
period. And during circulatory arrest NO levels
slightly increased but not significantly compared
with the level at the end of cooling period. After
reperfusion started, NO levels increased further in
the control group, and the increases were statisti-
cally significant. In the treatment NO levels in-
creased further during the first hour after reperfu-
sion started, but during the next hour NO levels
gradually decreased. Compared with the level at the
Table I. Comparison of control and treatment groups
Pre-CPB Pre-CA Post-CA Reperfusion 120 min
Body temperature (°C) Control 37.1 6 0.6 29.0 6 3.2* 25.5 6 1.5* 33.7 6 3.6
Treatment 37.8 6 1.4 26.2 6 2.5* 24.5 6 1.6* 33.0 6 1.0
Brain temperature (°C) Control 35.6 6 0.9 20.8 6 0.7* 20.0 6 0.5* 35.7 6 0.7
Treatment 35.8 6 1.1 21.3 6 0.7* 19.8 6 0.4* 35.5 6 0.9
Blood pressure (mm Hg) Control 126 6 15 65 6 8* 62 6 9* 65 6 12*
Treatment 133 6 19 59 6 12* 55 6 12* 101 6 39
Cerebral blood flow (ml/min/100 gm) Control 18.5 6 7.8 15.0 6 4.3 19.2 6 6.9 22.1 6 1.9
Treatment 18.3 6 4.9 15.9 6 2.8 17.8 6 1.8 23.1 6 4.0
AST (IU/L) Control 36 6 9 68 6 28 88 6 75 206 6 149*
Treatment 36 6 12 53 6 8 78 6 48 190 6 83*
LD (IU/L) Control 1140 6 226 1259 6 423 1336 6 543 2124 6 1214*
Treatment 1145 6 164 1393 6 573 1433 6 483 1960 6 820*
Excess lactate (mmol/L) Control 0.09 6 0.22 22.89 6 4.38 23.61 6 5.27 214.84 6 14.52
Treatment 0.10 6 0.25 21.39 6 1.58 25.94 6 2.88 217.36 6 15.21
AST, Aspartate aminotransferase; LD, lactic dehydrogenase; CPB, cardiopulmonary bypass; CA, circulatory arrest.
*Significant difference compared with pre-CPB with p value ,0.05 with 95% confidence interval.
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end of cooling period the increase after 60 minutes
of reperfusion was statistically significant, but not
after 120 minutes of reperfusion. A significant dif-
ference was observed between the groups regarding
NO level after 120 minutes of reperfusion (p 5
0.004).
Cerebral tissue water content. Cerebral tissue
water contents were 82.4% 6 0.2% in the control
group and 82.0% 6 0.5% in the treatment group.
No significant difference was found between the
groups. This meant that the extent of brain edema in
both groups was comparable.
SEP. As brain temperature fell, electroencepha-
lographic activity diminished and disappeared by
20° C. In all cases the electroencephalogram re-
mained flat during circulatory arrest. SEP was taken
at 60 minutes after reperfusion started, but none in
both groups showed recovery of SEP. After 120
minutes of reperfusion, SEP was detected in all the
cases in the treatment group but none in the control
group. This difference was significant (p 5 0.001).
Discussion
Several former studies reported that NO concen-
tration within the brain increased during normo-
thermic ischemia and reperfusion.1-4 This study
demonstrated the changes in NO levels within the
brain during hypothermic circulatory arrest and
reperfusion with cardiopulmonary bypass.
In this study, after CPB started, NO levels within
the brain decreased in proportion to brain temper-
ature decrease during the cooling period. NO levels
increased slightly during ischemia at a brain temper-
ature of 20° C and increased remarkably during
reperfusion. It was thought that this increase of NO
during reperfusion was one cause of reperfusion
injury of the brain and that inhibition of this in-
crease might lead to protection of the brain against
reperfusion injury.
Some NOSIs are used in many experiments.
Among them we chose L-NAME because it is re-
ported that L-NAME inhibits NO production par-
ticularly and is suitable for cerebral experiments.5
NOSIs such as L-NAME are reported to reduce
infarct size resulting from transient occlusion of the
middle cerebral artery of rats and mice.6 Because
NO works as a vasodilator, inhibition of NO pro-
duction may induce vasoconstriction and a subse-
quent increase in blood pressure. Ashwal and col-
leagues8 demonstrated that even a low dose of
Fig. 1. Changes of nitric oxide levels within the brain. f, control group; l, treatment group. In the
treatment group the levels of nitric oxide did not increase during the second 60 minutes after circulatory
arrest and a significant difference was observed between the groups regarding nitric oxide level after 120
minutes of reperfusion. The shaded rectangle shows the circulatory arrest. CPB, Cardiopulmonary bypass;
#significant difference between the groups with p value 0.004; *significant difference with p value , 0.05
compared with the value of precirculatory arrest with 95% confidence interval.
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L-NAME, which did not cause an increase in blood
pressure, had the same protective effect. They
proved that this effect did not result from an in-
crease in blood pressure. In our study L-NAME
caused an increase in blood pressure but no signif-
icant change in regional cerebral blood flow, there-
fore the protective effect of L-NAME was not due to
an increase in cerebral blood flow. On the other
hand, some studies reported that NO was neuropro-
tective9 or NOSI harmed cerebral tissue10 during
and after ischemia. Tsui and colleagues11 reported
L-NAME (50 mg/kg) aggravated cerebral blood flow
and oxygen metabolism, whereas L-arginine (30 mg/
kg) improved recovery after deep hypothermic cir-
culatory arrest using little piglets. Hiramatsu and
colleagues12 reported in their study with piglets
weighing about 4 kg that L-NAME administered
before CPB had a deleterious effect on cerebral
metabolic recovery. However, the dosage of
L-NAME in these studies differed considerably from
that in our study. Anderson and colleagues13 re-
ported only low-dose (, 1 mg/kg) L-NAME atten-
uated brain acidosis, and high-dose L-NAME had
contradictory effects during repetitive focal cerebral
ischemia. Other things, such as time for administra-
tion and condition of CPB, also differed and NO
levels were not measured. Moreover, the vulnerabil-
ity of the developing central nervous system to
hypoxia-ischemia is reported to differ from that of
the mature brain.14 Therefore it is difficult to com-
pare our study with theirs.
These two apparently contradictory opinions, that
NO is neurotoxic or neuroprotective, are in fact
compatible. One of the reasons is that NO could
take two different forms with quite different actions,
a radical form and an ionized form, depending on
surrounding conditions.15 Although it is reported
that the NO ion protects the cerebral tissue by
inhibiting the function of N-methyl-D-aspartate re-
ceptor against glutamate-mediated neurotoxicity,
NO radicals react with active oxygen and produce
peroxynitrite, which harms the cerebral tissue.16
7-Nitroindazole, which inhibited only neuronal
NO synthase, was reported to decrease cerebral
infarct size caused by middle cerebral artery occlu-
sion.17 Moreover, it was reported that ischemic
injury was reduced in mice that were inherently
deficient in neuronal NO synthase.18 Therefore
overabundant NO synthesized by neurons is thought
to be an aggravating factor of ischemic injury.
However, by maintaining blood flow the neuro-
protective effects of NO are expected because NO
essentially has a vasodilatative action and inhibits
platelet aggregation. Moreover, NO inhibits leuko-
cyte emigration and adherence to vascular endothe-
lium.19 Therefore it is expected that NO reduces the
no reflow phenomenon during reperfusion and neu-
rotoxicity of the superoxide anion deriving from
leukocytes. It is reported that excess NO synthesized
by neurons may be neurotoxic and NO deriving
from endothelium may be neuroprotective.14 Ac-
cording to our study, recovery of SEP indicates
preservation of the cerebral function better than the
recovery of electroencephalographic findings, and
L-NAME was supposed to work neuroprotectively.
Permeability of the blood-brain barrier is acti-
vated during brain ischemia, and vasogenic brain
edema occurs. It was reported that NO might take a
role in this activation,20 and NOSI reduced brain
edema of rats subjected to ischemia.21 From our
experimental results the protective effect of NOSI
against brain edema could not be detected because
no significant difference was found between the
control and treatment groups regarding cerebral
tissue water content.
Extrapolation of animal data to humans must
always be applied with extreme caution; however,
the results of this study suggest that even if a
prolonged circulatory arrest happens, treatment for
reperfusion injury may salvage brain damage.
Conclusion
NO levels within the brain increased not during
ischemia but during reperfusion under hypothermic
circulatory arrest with CPB. NOSI (L-NAME) ad-
ministered at the onset of reperfusion inhibited NO
production and showed protective effects on the
brain in terms of recovery of SEP. Under hypother-
mic circulatory arrest, NO might be one of the
factors causing reperfusion injury after brain isch-
emia.
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